CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-04-03 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −3,000 | 195,656 | ||
| 2017-03-23 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $53.91 | $27K | 94,260 |
| 2017-03-23 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $53.91 | $27K | 94,300 |
| 2017-03-22 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $52.31 | $27K | 94,769 |
| 2017-03-22 | Cantley Lewis Clayton Jr. Director | Sale | −509 | $52.31 | $27K | 94,809 |
| 2017-03-20 | Biller Scott Chief Scientific Officer | Option exercise | +5,933 | $9.05 | $54K | 21,403 |
| 2017-03-20 | Biller Scott Chief Scientific Officer | Sale | −5,933 | $55.00 | $326K | 15,470 |
| 2017-03-20 | Biller Scott Chief Scientific Officer | Option exercise | +505 | $0.47 | $236 | 15,975 |
| 2017-03-20 | Biller Scott Chief Scientific Officer | Sale | −505 | $55.00 | $28K | 15,470 |
| 2017-03-20 | Biller Scott Chief Scientific Officer | Option exercise · Common stock (right to buy) | −505 | 4,969 | ||
| 2017-03-20 | Biller Scott Chief Scientific Officer | Option exercise · Common stock (right to buy) | −5,933 | 48,157 | ||
| 2017-03-06 | NELSEN ROBERT Director | Sale | −40 | $49.43 | $2K | 0 |
| 2017-03-03 | NELSEN ROBERT Director | Sale | −31,425 | $50.69 | $1.6M | 9,174 |
| 2017-03-03 | NELSEN ROBERT Director | Sale | −8,734 | $51.34 | $448K | 440 |
| 2017-03-03 | NELSEN ROBERT Director | Sale | −400 | $52.15 | $21K | 40 |
| 2017-03-01 | Schenkein David P Chief Executive Officer | Option exercise | +3,000 | $0.30 | $908 | 3,000 |
| 2017-03-01 | Schenkein David P Chief Executive Officer | Sale | −3,000 | $50.47 | $151K | 0 |
| 2017-03-01 | Schenkein David P Chief Executive Officer | Option exercise · Stock option (right to buy) | −3,000 | 198,656 | ||
| 2017-02-28 | NELSEN ROBERT Director | Sale | −27,622 | $49.47 | $1.4M | 60,836 |
| 2017-02-28 | NELSEN ROBERT Director | Sale | −20,237 | $50.18 | $1.0M | 40,599 |
Page 77 of 80 · 1,590 trades